| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.68B | +29.2% |
| Cost of Revenue | $1.54B | +26.6% |
| Gross Profit | $3.15B | +30.5% |
| R&D Expense | $1.97B | +10.4% |
| SG&A Expense | $549.7M | +33.3% |
| Operating Income | -$1.44B | +1.4% |
| Pre-tax Income | -$1.31B | -2.1% |
| Income Tax | $17.1M | +316.4% |
| Net Income | -$1.33B | -3.6% |
| EPS (Basic) | -$3.95 | -2.3% |
| EPS (Diluted) | -$3.95 | -2.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.83B | +7.6% |
| Accounts Receivable | $1.30B | +41.3% |
| Current Assets | $5.74B | -2.2% |
| Total Assets | $9.13B | +1.1% |
| Current Liabilities | $4.42B | +33.9% |
| Total Liabilities | $7.21B | +19.6% |
| Stockholders' Equity | $1.92B | -35.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.22B | +27.3% |
| Capital Expenditures | $101.6M | +119.6% |
| Investing Cash Flow | $312.2M | +63.8% |
| Financing Cash Flow | -$1.39B | -511.6% |
| Free Cash Flow | $1.12B | +22.6% |